Dr Monica Pernia speaks to ecancer about a recent study that confirmed extreme hypofractionation utilising stereotactic body radiation therapy is well tolerated in elderly prostate cancer patients.
The results of this study were presented at this year’s SIOG virtual meeting. Dr Pernia initially explains the main aims of the study and then moves on towards explaining the methodology of this paper.
She then talks about the key results of this study which prove that this method of radiation therapy is highly beneficial for older patients.
Dr Pernia gives reasoning as to why this method is well tolerated in elderly prostate cancer patients and says that extreme hypofractionation utilising stereotactic body radiation therapy can become the standard of care for these types of patients in the future.